Skip to main content Deutsch

2021

Sorry, this content is only available in German!

Ausgewählte Publikationen 2021

Fellinger J, Dall M, Holzinger D (2021) Therapeutic living communities for adults who are deaf and have intellectual disabilities: A conceptual model linking social communication and mental health. International Journal of Developmental Disabilities, 67(5):391-396.

Salzner J, Dall M, Weber C, Holzinger D, Fellinger J (2021) Deaf Residents With Intellectual Disabilities During the First Covid-19 Associated Lockdown. The Journal of Deaf Studies and Deaf Education, Volume 26, Issue 4, October 2021: 556–559

Bajbouj M, Panneck P, Winter SM, Ajami C, Alabdullah J, Benedikt Burger M, Haberlandner A, Hahn E, Heinz A, Heuser I, Hoyer A, Kluge U, Aichberger M, Repantis D, Schreiter S, Seybold J, Sutej I (2021) A Central Clearing Clinic to Provide Mental Health Services for Refugees in Germany. Front Public Health. 2021 Feb 1;9:635474

Suessenbacher-Kessler S, Gmeiner A, Diendorfer T, Schrank B, Unger A, Amering M (2021) A relationship of sorts: gender and auditory hallucinations in schizophrenia spectrum disorders. Arch Womens Ment Health 24(5):709-720.

Mitic M, Woodcock KA, Amering M, Krammer I, Stiehl KAM, Zehetmayer S, Schrank B (2021) Toward an Integrated Model of Supportive Peer Relationships in Early Adolescence: A Systematic Review and Exploratory Meta-Analysis. Front Psychol. 12:589403

Carlin GL, Baumgartner JS, Moftakhar T, König D, Negrin LL (2021) Impact of COVID-19 lockdown on suicide attempts : A retrospective analysis of the springtime admissions to the trauma resuscitation room at the Medical University of Vienna from 2015-2020. Wien Klin Wochenschr. 2021 Sep;133(17-18):915-922

Niederkrotenthaler T, Baumgartner J, Kautzky A, Fellinger M, Jahn R, Wippel A, Koch M, König-Castillo D, Höflich A, Slamanig R, Topitz A, Wancata J, Till B (2021) Effects of media stories featuring coping with suicidal crises on psychiatric patients: Randomized controlled trial. Eur Psychiatry. 2021 Nov 4;64(1):e70

Mörkl S, Stell L, Buhai DV, Schweinzer M, Wagner-Skacel J, Vajda C, Lackner S, Bengesser SA, Lahousen T, Painold A, Oberascher A, Tatschl JM, Fellinger M, Müller-Stierlin A, Serban AC, Ben-Sheetrit J, Vejnovic AM, Butler MI, Balanzá-Martínez V, Zaja N, Rus-Prelog P, Strumila R, Teasdale SB, Reininghaus EZ, Holasek SJ (2021) 'An Apple a Day'?: Psychiatrists, Psychologists and Psychotherapists Report Poor Literacy for Nutritional Medicine: International Survey Spanning 52 Countries. Nutrients. 2021 Mar 2;13(3):822

Martens MAG, Kaltenboeck A, Halahakoon DC, Browning M, Cowen PJ, Harmer CJ (2021) An Experimental Medicine Investigation of the Effects of Subacute Pramipexole Treatment on Emotional Information Processing in Healthy Volunteers. Pharmaceuticals (Basel). 2021 Aug 14;14(8):800

Charpentier CJ, Faulkner P, Pool ER, Ly V, Tollenaar MS, Kluen LM, Fransen A, Yamamori Y, Lally N, Mkrtchian A, Valton V, Huys QJM, Sarigiannidis I, Morrow KA, Krenz V, Kalbe F, Cremer A, Zerbes G, Kausche FM, Wanke N, Giarrizzo A, Pulcu E, Murphy S, Kaltenboeck A, Browning M, Paul LK, Cools R, Roelofs K, Pessoa L, Harmer CJ, Chase HW, Grillon C, Schwabe L, Roiser JP, Robinson OJ, O'Doherty JP (2021) How representative are neuroimaging samples? Large-scale evidence for trait anxiety differences between fMRI and behaviour-only research participants. Soc Cogn Affect Neurosci. 2021 Sep 30;16(10):1057-1070

Kautzky A, Möller HJ, Dold M, Bartova L, Seemüller F, Laux G, Riedel M, Gaebel W, Kasper S (2021) Combining machine learning algorithms for prediction of antidepressant treatment response. Acta Psychiatr Scand. 2021 Jan;143(1):36-49

Kautzky A, Heneis K, Stengg K, Fröhlich S, Kautzky-Willer A (2021) Short Term Caloric Restriction and Biofeedback Enhance Psychological Wellbeing and Reduce Overweight in Healthy Women. J Pers Med. 2021 Oct 26;11(11):1096.

Leutner M, Matzhold C, Kautzky A, Kaleta M, Thurner S, Klimek P, Kautzky-Willer A (2021) Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment. Front Med (Lausanne). 2021 Feb 11;8:608083

Leutner M, Haug N, Bellach L, Dervic E, Kautzky A, Klimek P, Kautzky-Willer A (2021) Risk of Typical Diabetes-Associated Complications in Different Clusters of Diabetic Patients: Analysis of Nine Risk Factors. J Pers Med. 2021 Apr 22;11(5):328

Leutner M, Kaleta M, Bellach L, Kautzky A, Thurner S, Klimek P, Kautzky-Willer A (2021) Insulin as Monotherapy and in Combination with Other Glucose-Lowering Drugs Is Related to Increased Risk of Diagnosis of Pneumonia: A Longitudinal Assessment over Two Years. J Pers Med. 2021 Sep 29;11(10):984

McLaverty A, Allott KA, Berger M, Hester R, McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Amminger GP (2021) Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis. Early Interv Psychiatry. 2021 Aug;15(4):874-881

O'Donoghue B, Geros H, Sizer H, Addington J, Amminger GP, Beaden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Berger GE, Chen EYH, de Haan L, Hartmann JA, Hickie IB, Ising HK, Lavoie S, Lin A, Markulev C, Mathalon DH, McGlashan TH, Mifsud NG, Mossaheb N, Nieman DH, Nordentoft M, Perkins DO, Riecher-Rössler A, Schäfer MR, Schlögelhofer M, Seidman LJ, Smesny S, Thompson A, Tsuang MT, van der Gaag M, Verma S, Walker EF, Wood SJ, Woods SW, Yuen HP, Yung AR, McGorry PD, Nelson B. (2021) The association between migrant status and transition in an ultra-high risk for psychosis population. Soc Psychiatry Psychiatr Epidemiol. 2021 Jun;56(6):943-952

Sandini C, Zöller D, Schneider M, Tarun A, Armando M, Nelson B, Amminger PG, Yuen HP, Markulev C, Schäffer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EY, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD, Van De Ville D, Eliez S (2021) Characterization and prediction of clinical pathways of vulnerability to psychosis through graph signal processing. Elife. 2021 Sep 27;10:e59811

Hinterbuchinger B, Mossaheb N (2021) Psychotic-Like Experiences: A Challenge in Definition and Assessment. Front Psychiatry. 2021 Mar 29;12:582392

Michel C, Berger M, Mossaheb N, Kindler J (2021) Editorial: Clinical High Risk for Psychosis: From Epidemiological Findings to Neurobiological Underpinnings of Treatment Response and Outcome. Front Psychiatry. 2021 Nov 18;12:790810

Zrzavy T, Endmayr V, Bauer J, Macher S, Mossaheb N, Schwaiger C, Ricken G, Winklehner M, Glatter S, Breu M, Wimmer I, Kovacs GG, Risser DU, Klupp N, Simonitsch-Klupp I, Roetzer T, Rommer P, Berger T, Gelpi E, Lassmann H, Graus F, Dalmau J, Höftberger R (2021) Neuropathological Variability within a Spectrum of NMDAR-Encephalitis. Ann Neurol. 2021 Nov;90(5):725-737

van der Heijden HS, Schirmbeck F, McGuire P, Valmaggia LR, Kempton MJ, van der Gaag M, Nelson B, Riecher-Rössler A, Bressan R, Barrantes-Vidal N, Ruhrmann S, Sachs G, de Haan L, Vermeulen JM (2021) EU-GEI High Risk Study. Association between tobacco use and symptomatology in individuals at ultra-high risk to develop a psychosis: A longitudinal study. Schizophr Res. 2021 Oct;236:48-53

Ong HL, Isvoranu AM, Schirmbeck F, McGuire P, Valmaggia L, Kempton MJ, van der Gaag M, Riecher-Rössler A, Bressan RA, Barrantes-Vidal N, Nelson B, Amminger GP, McGorry P, Pantelis C, Krebs MO, Nordentoft M, Glenthøj B, Ruhrmann S, Sachs G, Rutten BPF, van Os J, de Haan L, Borsboom D; EU-GEI High Risk Study (2021) Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis: A Network Perspective. Schizophr Bull. 2021 Jul 8;47(4):1018-1028

Velthorst E, Mollon J, Murray RM, de Haan L, Germeys IM, Glahn DC, Arango C, van der Ven E, Di Forti M, Bernardo M, Guloksuz S, Delespaul P, Mezquida G, Amoretti S, Bobes J, Saiz PA, García-Portilla MP, Santos JL, Jiménez-López E, Sanjuan J, Aguilar EJ, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Atbaşoğlu C, Saka MC, Üçok A, Alptekin K, Akdede B, Binbay T, Altınyazar V, Ulaş H, Yalınçetin B, Gümüş-Akay G, Beyaz BC, Soygür H, Cankurtaran EŞ, Kaymak SU, Maric NP, Mihaljevic MM, Petrovic SA, Mirjanic T, Del-Ben CM, Ferraro L, Gayer-Anderson C, Jones PB, Jongsma HE, Kirkbride JB, La Cascia C, Lasalvia A, Tosato S, Llorca PM, Menezes PR, Morgan C, Quattrone D, Menchetti M, Selten JP, Szöke A, Tarricone I, Tortelli A, McGuire P, Valmaggia L, Kempton MJ, van der Gaag M, Riecher-Rössler A, Bressan RA, Barrantes-Vidal N, Nelson B, McGorry P, Pantelis C, Krebs MO, Ruhrmann S, Sachs G, Rutten BPF, van Os J, Alizadeh BZ, van Amelsvoort T, Bartels-Velthuis AA, Bruggeman R, van Beveren NJ, Luykx JJ, Cahn W, Simons CJP, Kahn RS, Schirmbeck F, van Winkel R; EU-GEI High Risk Study; Reichenberg A (2021) Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings. Mol Psychiatry. 2021 Aug;26(8):4529-4543

Sachs G, Lasser I, Purdon SE, Erfurth A  (2021) Screening for cognitive impairment in schizophrenia: Psychometric properties of the German version of the Screen for Cognitive Impairment in Psychiatry (SCIP-G). Schizophr Res Cogn. 2021 May 12;25:100197

Purgato M, Carswell K, Tedeschi F, Acarturk C, Anttila M, Au T, Bajbouj M, Baumgartner J, Biondi M, Churchill R, Cuijpers P, Koesters M, Gastaldon C, Ilkkursun Z, Lantta T, Nosè M, Ostuzzi G, Papola D, Popa M,, Roselli V, Sijbrandij M, Tarsitani L, Turrini G, Välimäki M, Walker L, Wancata J, Zanini E, White R, van Ommeren M, Barbui C (2021) Effectiveness of Self-Help Plus in Preventing Mental Disorders in Refugees and Asylum Seekers in Western Europe: A Multinational Randomized Controlled Trial. Psychotherapy and Psychosomatics, 2021;90 (6):403–414

Iozzino L, Harvey PD, Canessa N, Gosek P, Heitzman J, Macis A, Picchioni M, Salize HJ, Wancata J, Koch M, Ferrari C, de Girolamo G (2021) Neurocognition and social cognition in patients with schizophrenia spectrum disorders with and without a history of violence: results of a multinational European study. Translation Psychiatry 11 (1):620

Rabady S, Altenberger J, Brose M, Denk-Linnert DM, Fertl E, Götzinger F, de la Cruz Gomez Pellin M, Hofbaur B, Hoffmann K, Hoffmann-Dorninger R, Koczulla R, Lammel O, Lamprecht B, Löffler-Ragg J, Müller CA, Poggenburg S, Rittmannsberger H, Sator P, Strenger V, Vonbank V, Wancata J, Weber T, Weber J, Weiss G, Wendler M, Zwick RH (2021) Leitlinie S1: Long COVID: Differenzialdiagnostik und Behandlungsstrategien. Wiener Klinische Wochenschrift 133 (Suppl 7):237–278

Karyotakia E, Sijbrandij M, Purgato M, Acarturk C, Lakin D, Bailey D, Peckham E, Uygun E, Tedeschi F, Wancata J, Augustinavicius J, Carswell K, Välimäki M, van Ommeren M, Koesters M, Popa M, Leku MR, Anttila M, Churchill R, White R, Al-Hashimi S, Lantta T, Au T, Klein T, Tol WA, Cuijpers P, Barbui C (2021) Self-help plus for refugees and asylum seekers; study protocol for a series of individual participant data meta-analyses. European Journal of Psychotraumatology 2021, 12 (1):1930690

Slamanig R, Reisegger A, Winkler H, de Girolamo G, Carrà G, Crocamo C, Fangerau H, Markiewicz I, Heitzman J, Salize HJ, Picchioni M, Wancata J (2021) A Systematic Review of Non-pharmacological Strategies to Reduce the Risk of Violence in Patients With Schizophrenia Spectrum Disorders in Forensic Settings. Frontiers in Psychiatry, 12:618860

de Girolamo G, Iozzino L, Ferrari C, Gosek P, Heitzman J, Salize HJ, Wancata J, Picchioni M, Macis A (2021). A multinational case−control study comparing forensic and non-forensic patients with schizophrenia spectrum disorders: the EU-VIORMED project. Psychological Medicine (2021):1–11

Pollak TA, Kempton MJ, Iyegbe C, Vincent A, Irani SR, Coutinho E, Menassa DA, Jacobson L, de Haan L, Ruhrmann S, Sachs G, Riecher-Rössler A, Krebs MO, Amminger P, Glenthøj B, Barrantes-Vidal N, van Os J, Rutten BPF, Bressan RA, van der Gaag M, Yolken R, Hotopf M, Valmaggia L, Stone J, David AS; EUGEI High-Risk Study; McGuire P (2021) Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis. Mol Psychiatry. 2021 Jun;26(6):2590-2604